李兴梅, 贺璞流芳, 胡杰, 李蒙. T2DM患者血清过氧化还原酶1水平与抑郁症状及主观应激间的关系[J]. 广西医科大学学报, 2023, 40(8): 1369-1375. DOI: 10.16190/j.cnki.45-1211/r.2023.08.016
引用本文: 李兴梅, 贺璞流芳, 胡杰, 李蒙. T2DM患者血清过氧化还原酶1水平与抑郁症状及主观应激间的关系[J]. 广西医科大学学报, 2023, 40(8): 1369-1375. DOI: 10.16190/j.cnki.45-1211/r.2023.08.016
Li Xingmei, He-Pu Liufang, Hu Jie, Li Meng. Relationship between serum peroxiredoxin 1 level and depressive symptoms and subjective stress in T2DM patients[J]. Journal of Guangxi Medical University, 2023, 40(8): 1369-1375. DOI: 10.16190/j.cnki.45-1211/r.2023.08.016
Citation: Li Xingmei, He-Pu Liufang, Hu Jie, Li Meng. Relationship between serum peroxiredoxin 1 level and depressive symptoms and subjective stress in T2DM patients[J]. Journal of Guangxi Medical University, 2023, 40(8): 1369-1375. DOI: 10.16190/j.cnki.45-1211/r.2023.08.016

T2DM患者血清过氧化还原酶1水平与抑郁症状及主观应激间的关系

Relationship between serum peroxiredoxin 1 level and depressive symptoms and subjective stress in T2DM patients

  • 摘要: 目的:分析血清过氧化还原酶1(PRDX1)水平与2 型糖尿病(T2DM)患者抑郁症状及主观应激的相关性。方法:选择2019年7月至2021年12月陕西省榆林市第二医院的256例T2DM患者,根据抑郁—焦虑—压力量表-21(DASS-21)抑郁评分将患者分为抑郁症状组(n=56)及无抑郁症状组(n=200)。采用酶联免疫吸附法检测血清PRDX1水平。根据DASS-21评估患者心理状态。采用压力知觉量表(PSS)评估患者的主观应激程度。结果:根据DASS-21评分,抑郁症状组中血清PRDX1水平显著高于无抑郁症状组的患者(P< 0.05);所有T2DM 患者血清PRDX1 水平为(12.98±3.70)ng/mL,且血清PRDX1 水平与DASS-21抑郁评分和压力评分均呈正相关关系(P< 0.05);经受试者工作特征曲线分析,血清PRDX1水平诊断T2DM合并抑郁症状的曲线下面积为0.767(95%CI:0.699~0.835),灵敏性、特异性分别为87.5%、68.5%;经Pearson相关性分析和校正多种干扰因素的多元线性回归分析,血清PRDX1水平与有抑郁症状的T2DM患者PSS评分呈正相关关系(P< 0.001),但与无抑郁症状的患者PSS评分无相关关系(r=0.076,P=0.283)。此外,对于有抑郁症状的T2DM患者,血清PRDX1水平与IL-6、TNF-α水平亦呈正相关关系(P< 0.001)。结论:血清PRDX1水平对诊断T2DM患者是否合并抑郁症有良好的效能,且对于出现抑郁症状的T2DM患者,血清PRDX1水平持续增加与患者机体低度炎症反应以及主观应激程度有关。

     

    Abstract: Objective:To analyze the correlation between serum peroxiredoxin 1 (PRDX1) level and depressive symptoms and subjective stress in patients with type 2 diabetes mellitus(T2DM).Methods:A total of 256 T2DM patients from Yulin No.2 Hospital, Shaanxi Province from July 2019 to December 2021 were recruited and divided into depression symptom group(n=56)and non-depression symptom group(n=200)according to the depression score of Depression Anxiety Stress Scales-21 (DASS-21).Serum PRDX1 levels were detected by enzymelinked immunosorbent assay.The psychological state of patients was evaluated according to DASS-21.Perceived Stress Scale(PSS)was used to evaluate the subjective stress degree of patients.Results:According to the DASS-21 score, the serum PRDX1 levels in the depressive symptom group were significantly higher than those in the non-depressive symptom group (P< 0.05).The serum PRDX1 levels in all T2DM patients were 12.98±3.70 ng/mL, and the serum PRDX1 levels were positively correlated with the DASS-21 depression score and stress score(P< 0.05).According to the receiver operating characteristic curve analysis, the area under the curve of serum PRDX1 level in diagnosing T2DM complicated with depressive symptoms was 0.767(95%CI:0.699-0.835), and the sensitivity and specificity were 87.5% and 68.5%, respectively.Pearson correlation analysis and multiple linear regression analysis corrected for multiple interfering factors showed that serum PRDX1 level was positively correlated with PSS score in T2DM patients with depressive symptoms(P< 0.001), but not with PSS score in T2DM patients without depressive symptoms (r=0.076, P=0.283).In addition, serum PRDX1 levels were positively correlated with IL-6 and TNF-α levels in T2DM patients with depressive symptoms (P< 0.001).Conclusion:The serum PRDX1 levels have a good efficacy in the diagnosis of depression in T2DM patients, and for T2DM patients with depressive symptoms, the continuous increase of serum PRDX1 levels is related to the low-grade inflammatory reaction and the degree of subjective stress.

     

/

返回文章
返回